Developing AI second-reading tools for mammography and breast MRI
Dense breast tissue makes mammograms harder to interpret, and nearly half of women aged 40 and older who undergo mammography have dense breasts. Breast density cannot be assessed by touch: it requires a radiologist to review the mammogram.
Synapsis Labs develops AI second-reading tools for mammography and breast MRI to help radiologists flag findings and prepare reports. Sentinel and Nexus support, rather than replace, clinical judgment.
What stands out about Synapsis Labs
Reports €220,000 ARR in signed deals in its Elevate Greece profile.
Reports a scientific collaboration with Iatropolis providing access to imaging data and radiology expertise for R&D.
Synapsis was selected for Pfizer CDI’s Start4Health 2025 Acceleration Lab, with mentoring and product-development support.
Co-founder Angelos Roussakis previously founded and ran Versasoft, a web-development company, from 2010 to 2015.
Founder Angelos Roussakis reports Sentinel is live in three Greek diagnostic centres and generating revenue.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.